BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19393705)

  • 1. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer.
    Lu Y
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):572-88. PubMed ID: 19393705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for prostate cancer: where are we now?
    Steiner MS; Gingrich JR
    J Urol; 2000 Oct; 164(4):1121-36. PubMed ID: 10992352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of transcriptionally regulated oncolytic adenoviruses.
    Ko D; Hawkins L; Yu DC
    Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
    Hsieh CL; Chung LW
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated cancer gene therapy and virotherapy (Review).
    Fukazawa T; Matsuoka J; Yamatsuji T; Maeda Y; Durbin ML; Naomoto Y
    Int J Mol Med; 2010 Jan; 25(1):3-10. PubMed ID: 19956895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral-based gene delivery and regulated gene expression for targeted cancer therapy.
    Lu Y; Madu CO
    Expert Opin Drug Deliv; 2010 Jan; 7(1):19-35. PubMed ID: 19947888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different approaches of gene therapy used in prostate cancer.
    Ghosh A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):103-11. PubMed ID: 16171569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-based therapy for prostate cancer.
    Ekblad M; Halldén G
    Curr Opin Mol Ther; 2010 Aug; 12(4):421-31. PubMed ID: 20677093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic virus therapy for prostate cancer.
    Fukuhara H; Homma Y; Todo T
    Int J Urol; 2010 Jan; 17(1):20-30. PubMed ID: 19832925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-modified bone marrow cell therapy for prostate cancer.
    Wang H; Thompson TC
    Gene Ther; 2008 May; 15(10):787-96. PubMed ID: 18385769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
    Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
    Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic.
    Miyake H; Hara I; Gleave ME
    Int J Urol; 2005 Sep; 12(9):785-94. PubMed ID: 16201973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From gene therapy to virotherapy for ovarian cancer.
    Stoff-Khalili MA; Dall P; Curiel DT
    Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
    Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
    Liu TC; Galanis E; Kirn D
    Nat Clin Pract Oncol; 2007 Feb; 4(2):101-17. PubMed ID: 17259931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic viral therapies - the clinical experience.
    Aghi M; Martuza RL
    Oncogene; 2005 Nov; 24(52):7802-16. PubMed ID: 16299539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological principles and clinical development of prostate cancer gene therapy.
    Sanda MG
    Semin Urol Oncol; 1997 Feb; 15(1):43-55. PubMed ID: 9050139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.
    Norris JS; Bielawska A; Day T; El-Zawahri A; ElOjeimy S; Hannun Y; Holman D; Hyer M; Landon C; Lowe S; Dong JY; McKillop J; Norris K; Obeid L; Rubinchik S; Tavassoli M; Tomlinson S; Voelkel-Johnson C; Liu X
    Cancer Gene Ther; 2006 Dec; 13(12):1045-51. PubMed ID: 16763610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer gene therapy and the role of radiation.
    Kaminski JM; Nguyen K; Buyyounouski M; Pollack A
    Cancer Treat Rev; 2002 Feb; 28(1):49-64. PubMed ID: 12027414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.